Alexion Pharmaceuticals

$182.50

+$3.05 (+1.70%) Today
$0.00 (0.00%) As of 11:21 PM UTC after-hours
1D
1W
1M
3M
1Y
5Y

Why Robinhood?

You can watch ALXN and buy or sell other stocks, options, and ETFs commission-free!

About ALXN

Alexion Pharmaceuticals is a biopharmaceutical company, which is engaged in the discovery, development, and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer, and autoimmune disorders. Its marketed product Soliris (eculizumab) is a therapy approved for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH). 

CEO
Marc Pierre Jean Dunoyer, MBA
CEOMarc Pierre Jean Dunoyer, MBA
Employees
Employees
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
1992
Founded1992
Employees
Employees

ALXN Key Statistics

Market cap
40.34B
Market cap40.34B
Price-Earnings ratio
59.70
Price-Earnings ratio59.70
Dividend yield
Dividend yield
Average volume
14.86M
Average volume14.86M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$187.45
52 Week high$187.45
52 Week low
$99.91
52 Week low$99.91

Analyst ratings

ALXN Earnings

$0.00
$1.17
$2.35
$3.52
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
per share
Estimated per share
Actual
Expected Oct 28, Pre-Market
ActualExpected Oct 28, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.